Cargando…

Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice

Erythropoietic protoporphyria (EPP) is caused by deficiency of ferrochelatase (FECH), which incorporates iron into protoporphyrin IX (PPIX) to form heme. Excitation of accumulated PPIX by light generates oxygen radicals that evoke excessive pain and, after longer light exposure, cause ulcerations in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barman-Aksözen, Jasmin, C´wiek, Paulina, Bansode, Vijay B., Koentgen, Frank, Trüb, Judith, Pelczar, Pawel, Cinelli, Paolo, Schneider-Yin, Xiaoye, Schümperli, Daniel, Minder, Elisabeth I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Ltd 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374324/ https://www.ncbi.nlm.nih.gov/pubmed/28093505 http://dx.doi.org/10.1242/dmm.027755

Ejemplares similares

Delivery of oligonucleotides to bone marrow to modulate ferrochelatase splicing in a mouse model of erythropoietic protoporphyria
por: Halloy, François, et al.
Publicado: (2020)

Increased phototoxic burn tolerance time and quality of life in patients with erythropoietic protoporphyria treated with afamelanotide – a three years observational study
por: Barman-Aksözen, Jasmin, et al.
Publicado: (2020)

Current trials in erythropoietic protoporphyria: are placebo controls ethical?
por: Barman-Aksözen, Jasmin, et al.
Publicado: (2023)

Validation of a novel patient reported tool to assess the impact of treatment in erythropoietic protoporphyria: the EPP-QoL
por: Biolcati, G., et al.
Publicado: (2021)

Quality-Adjusted Life Years in Erythropoietic Protoporphyria and Other Rare Diseases: A Patient-Initiated EQ-5D Feasibility Study
por: Barman-Aksözen, Jasmin, et al.
Publicado: (2023)

Correction to: Validation of a novel patient reported tool to assess the impact of treatment in erythropoietic protoporphyria: the EPP-QoL
por: Biolcati, G., et al.
Publicado: (2021)

Beyond pigmentation: signs of liver protection during afamelanotide treatment in Swiss patients with erythropoietic protoporphyria, an observational study
por: Minder, Anna-Elisabeth, et al.
Publicado: (2021)

Erythropoietic protoporphyria
por: Lecha, Mario, et al.
Publicado: (2009)

Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria
por: Minder, Anna-Elisabeth, et al.
Publicado: (2023)

Level of Expression of the Nonmutant Ferrochelatase Allele is a Determinant of Biochemical Phenotype in a Mouse Model of Erythropoietic Protoporphyria
por: Bloomer, Joseph, et al.
Publicado: (2008)

Heme Biosynthetic Gene Expression Analysis With dPCR in Erythropoietic Protoporphyria Patients
por: Granata, Francesca, et al.
Publicado: (2022)

Microcytosis in Erythropoietic Protoporphyria
por: Graziadei, Giovanna, et al.
Publicado: (2022)

How I treat erythropoietic protoporphyria and X-linked protoporphyria
por: Leaf, Rebecca Karp, et al.
Publicado: (2023)

The role of ClpX in erythropoietic protoporphyria
por: Whitman, Jared C., et al.
Publicado: (2018)

UK experience of liver transplantation for erythropoietic protoporphyria
por: Dowman, Joanna K., et al.
Publicado: (2011)

Laparoscopic Cholecystectomy in a Patient with Erythropoietic Protoporphyria
por: Roe, Thomas, et al.
Publicado: (2010)

Advances in the management of erythropoietic protoporphyria – role of afamelanotide
por: Lane, Ashley M, et al.
Publicado: (2016)

Evidence in the UK Biobank for the underdiagnosis of erythropoietic protoporphyria
por: Dickey, Amy K., et al.
Publicado: (2020)

A pilot study of oral iron therapy in erythropoietic protoporphyria and X-linked protoporphyria
por: Balwani, Manisha, et al.
Publicado: (2022)

An Unusual Case of Erythropoietic Protoporphyria Mimicking Lipoid Proteinosis
por: Kaur, Sarabjit, et al.
Publicado: (2019)

Erythropoietic Protoporphyria-related Hepatopathy Successfully Treated with Phlebotomy
por: Yoshida, Akihiro, et al.
Publicado: (2018)

Recognized and Emerging Features of Erythropoietic and X-Linked Protoporphyria
por: Di Pierro, Elena, et al.
Publicado: (2022)

Erythropoietic protoporphyria: Delayed presentation with decompensated liver disease
por: Sarda, Radhika, et al.
Publicado: (2020)

Erythropoietic protoporphyria: case reports for clinical and therapeutic hints
por: Tumminelli, Cristina, et al.
Publicado: (2023)

Evaluating quality of life tools in North American patients with erythropoietic protoporphyria and X‐linked protoporphyria
por: Naik, Hetanshi, et al.
Publicado: (2019)

Prevention of photosensitivity with action spectrum adjusted protection for erythropoietic protoporphyria
por: Teramura, Takashi, et al.
Publicado: (2017)

The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria
por: Wang, Pengcheng, et al.
Publicado: (2019)

Erythropoietic Protoporphyria Masquerading as Angioedema in a 4-Year-Old Female
por: Wang, Helen C, et al.
Publicado: (2006)

Liver transplantation for acute-on-chronic liver failure from erythropoietic protoporphyria
por: Park, Pyoung-Jae, et al.
Publicado: (2012)

Bovine congenital erythropoietic protoporphyria in a crossbred limousin heifer in Ireland
por: McAloon, Conor G., et al.
Publicado: (2015)

Delayed photosensitivity in a child with erythropoietic protoporphyria : a case report
por: Kiberd, James, et al.
Publicado: (2018)

Diagnosis of erythropoietic protoporphyria with severe liver injury: A case report
por: Liu, Hui-Min, et al.
Publicado: (2019)

Management of erythropoietic protoporphyria with cholestatic liver disease: A case report
por: Poli, Antoine, et al.
Publicado: (2023)

Patient-recorded outcome to assess therapeutic efficacy in protoporphyria-induced dermal phototoxicity: a proposal
por: Minder, Elisabeth I, et al.
Publicado: (2010)

The 6-year follow-up of a Japanese patient with silent erythropoietic protoporphyria
por: Mizawa, Megumi, et al.
Publicado: (2017)

Microvascular Hepatic Artery Anastomosis in Living Donor Liver Transplantation for Erythropoietic Protoporphyria
por: Yamashita, Shuji, et al.
Publicado: (2020)

Characterization of a novel pathogenic variant in the FECH gene associated with erythropoietic protoporphyria
por: Kieke, Michele C., et al.
Publicado: (2019)

Erythropoietic Protoporphyria: You May Not Have Seen It, but It May Have Seen You
por: Pastore, Larissa M, et al.
Publicado: (2022)

In vitro Assessment of Solar Filters for Erythropoietic Protoporphyria in the Action Spectrum of Protoporphyrin IX
por: Sernicola, Alvise, et al.
Publicado: (2021)

Protection from phototoxic injury during laparoscopic surgery in patients with erythropoietic protoporphyria
por: Pielaciński, Konrad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fiedb5l09js3p7mguvqs73pvnr